+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of long-term nocturnal oxygen treatment in patients with severe heart failure



Effects of long-term nocturnal oxygen treatment in patients with severe heart failure



Journal of Cardiovascular Nursing 20(6): 385-396



Sleep-disordered breathing (SDB) is common in patients with heart failure (HF) and leads to disturbed sleep. The objective of this study was to determine the persistent effects of long-term nocturnal oxygen treatment in patients with severe HF regarding (1) objective outcomes, such as sleep, SDB, cardiac function, and functional capacity; (2) subjective outcomes, such as self-assessed sleep difficulties, daytime sleepiness, and health-related quality of life (HRQOL); and (3) the relationship between objective and subjective outcomes. In this open nonrandomized experimental study, 22 patients, median age 71 years, with severe HF were studied before and after 3 months of receiving nocturnal oxygen. The measures used were overnight polysomnography, echocardiography, 6-minute walk test, self-assessed sleep difficulties (Uppsala Sleep Inventory-HF), daytime sleepiness (Epworth Sleepiness Scale), and HRQOL (36-Item Short Form Health Survey and Minnesota Living with Heart Failure Questionnaire). SDB, with a 90% dominance of central sleep apnea, occurred in 41% of the patients with severe HF before intervention. After intervention, functional capacity improved for both the whole group of patients with HF (P < .01) and HF patients with SDB (P < .05). No improvements regarding cardiac function, objective sleep, subjective sleep, or SDB were seen, except for a decrease of > or = 4% desaturations (P < .05). HRQOL did not differ significantly between HF patients with and without SDB before or after intervention with nocturnal oxygen. Long-term nocturnal oxygen treatment improved functional capacity in patients with severe HF, with or without SDB. No improvements were seen regarding sleep, daytime sleepiness, SDB, cardiac function, or HRQOL.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 048910720

Download citation: RISBibTeXText

PMID: 16485622


Related references

Short term and long term effects of treatment with low dose captopril in patients with severe congestive heart failure. British Journal of Clinical Pharmacology 14(Suppl. 2): 231S-235S, 1982

Short- and long-term effects of nocturnal oxygen therapy on sleep apnea in chronic heart failure. Sleep and Breathing 19(1): 159-168, 2015

Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure. British Journal of Clinical Pharmacology 14(Suppl. 2): 231s, 1982

Effectiveness of short-term treatment with nocturnal oxygen therapy for central sleep apnea in patients with congestive heart failure. Journal of Cardiology 46(2): 53-61, 2005

Comparative long-term effects of D,L-sotalol, metoprolol and amiodarone in the treatment of severe heart failure patients with life-threatening ventricular arrhythmia. European Heart Journal 18(ABSTR Suppl. ): 545, 1997

Long-term survival after MitraClip(®) therapy in patients with severe mitral regurgitation and severe congestive heart failure: A comparison among survivals predicted by heart failure models. Journal of Cardiology 67(3): 287-294, 2016

Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. Circulation 69(2): 298-305, 1984

Superiority of captopril to prazosin in the long term treatment of patients of with severe chronic heart failure. Journal of the American College of Cardiology 1(2 Part 2): 727, 1983

Exercise responses before and after long-term treatment with oral milrinone in patients with severe heart failure. American Journal of Medicine 81(5): 759-764, 1986

Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure. Arzneimittel-Forschung 36(2a): 394-397, 1986

Long-term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure. European Journal of Heart Failure 8(8): 804-809, 2006

Effect of long-term nocturnal oxygen on sleep quality and cognitive function in chronic heart failure with Cheyne-Stokes respiration. European Heart Journal 18(ABSTR Suppl. ): 290, 1997

Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure. British Journal of Clinical Pharmacology 14(Suppl. 2): 209s, 1982

Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study). American Journal of the Medical Sciences 342(1): 27-37, 2011